July 7, 2020

Volume X, Number 189

July 06, 2020

Subscribe to Latest Legal News and Analysis

National Nanotechnology Coordination Office Announces 2016 NNI Strategic Plan

On November 1, 2016, the National Nanotechnology Coordination Office (NNCO) announced the release of the 2016 National Nanotechnology Initiative Strategic Plan.  The 21st Century Nanotechnology Research and Development Act of 2003 requires National Nanotechnology Initiative (NNI) agencies to develop an updated Strategic Plan every three years. The 2016 Strategic Plan represents a consensus among the NNI agencies on the high-level goals and priorities of the NNI and on specific objectives to be pursued over at least the next three years. The Strategic Plan provides the framework under which individual agencies conduct their own mission-specific nanotechnology programs, coordinate these activities with those of other NNI agencies, and collaborate. The Strategic Plan states that the focus of the NNI has broadened from investments in foundational research in nanomaterials and nanotechnology-enabled devices to include activities directed at how they can be incorporated into nanotechnology-enabled systems. The 2016 Strategic Plan reflects this change and addresses how the NNI agencies will collaborate with each other and the broader nanotechnology community “to expand the ecosystem that supports fundamental discovery, fosters innovation, and promotes the transfer of nanotechnology discoveries from lab to market.”  The Strategic Plan includes the following goals:

  • Goal 1: Advance a world-class nanotechnology research and development program.  NNI agencies will foster research that exploits the convergence of nanotechnology, biotechnology, information technology, and cognitive science to lead to the next scientific breakthroughs and address key societal challenges.  NNI agencies will also promote the integration of modeling and simulation together with data analytics across the research and development spectrum to accelerate nanotechnology discovery. NNI agencies will continue to support a “diverse and robust portfolio” of Nanotechnology Signature Initiatives intended to provide additional focus and collaboration to accelerate technology development in areas of strategic national interest.

  • Goal 2: Foster the transfer of new technologies into products for commercial and public benefit.  The Strategic Plan notes that funding for Small Business Innovation Research and Small Business Technology Transfer has been instrumental in the transfer of nanotechnology products from lab to market.  NNI agencies will explore additional mechanisms to foster commercialization, innovation, and entrepreneurship.  NNI agencies will continue to support activities such as the National Science Foundation Innovation Corps, the National Institutes of Health Translation of Nanotechnology in Cancer Consortium, and the Air Force Research Laboratory-supported Nano-Bio Manufacturing Consortium to identify best practices that can be incorporated into new approaches to maximize the commercial benefit of NNI investments. NNI agencies will continue to engage with the international community in areas such as intellectual property, standards development, and the potential environmental, health, and safety implications of engineered nanomaterials and nanotechnology-enabled products.  NNI agencies will also forge new partnerships to advance nanotechnology commercialization and other NNI goals.

  • Goal 3: Develop and sustain educational resources, a skilled workforce, and a dynamic infrastructure and toolset to advance nanotechnology. NNI agencies will continue to promote the development of new experimental and computational tools to support advances in nanotechnology. The Strategic Plan states that NNI agencies will pursue an “evergreen” approach to physical infrastructure, continually supporting “workhorse” tools, in addition to providing support for the development of new tools and techniques and for workforce training to maintain these facilities.

  • Goal 4: Support responsible development of nanotechnology. NNI agencies will continue to support collaborative fundamental research to refine the understanding of the environmental, health, and safety implications of engineered nanomaterials and nanotechnology-enabled products, as discussed in the 2011 NNI Environmental, Health, and Safety Research Strategy. According to the Strategic Report, the ethical, legal, and societal implications of nanotechnology continue to be important issues for the NNI.  NNI agencies will pursue opportunities to collaborate with the nanotechnology community to share information and best practices. NNI agencies and NNCO will continue to collaborate internationally, such as the U.S.-European Union Communities of Research, to share information and coordinate activities, and look for new ways to promote global collaboration on the responsible development of nanotechnology.

©2020 Bergeson & Campbell, P.C.National Law Review, Volume VI, Number 308


About this Author

Lynn Bergeson, Campbell PC, Toxic Substances Control Act Attorney, federal insecticide lawyer, industrial biotechnology legal counsel, Food Drug Administration law
Managing Partner

Lynn L. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Her knowledge of and involvement in the policy process allows her to develop client-focused strategies whether...

Carla Hutton, Bergeson Campbell PC, global regulatory attorney, public health activists lawyer, metals industry legal counsel, Toxic Substances Control Act law
Regulatory Analyst

Since 1996, Carla Hutton has monitored, researched, and written about regulatory and legislative issues that may potentially affect Bergeson & Campbell, P.C. (B&C®) clients. She is responsible for creating a number of monthly and quarterly regulatory updates for B&C's clients, as well as other documents, such as chemical-specific global assessments of regulatory developments and trends. She authors memoranda for B&C clients on regulatory and legislative developments, providing information that is focused, timely and applicable to client initiatives. These tasks have proven invaluable to many clients, keeping them aware and abreast of developing issues so that they can respond in kind and prepare for the future of their business.

Ms. Hutton brings a wealth of experience and judgment to her work in federal, state, and international chemical regulatory and legislative issues, including green chemistry, nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the Toxic Substances Control Act (TSCA), Proposition 65, and the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) program.